Follow Us:
PARS‑LUTO TATE is a sterile, non‑pyrogen lyophilized radiopharmaceutical kit for the treatment of neuroendocrine tumors, which, after radiolabeling with Lu‑177, is used for this purpose. The LUTO TATE kit is intended solely for therapeutic use and for the preparation of 177Lu‑DOTATATE.
- Treatment of neuroendocrine tumors (NETs) such as those of the gastrointestinal tract, pancreas, small intestine, and stomach
- Treatment of metastatic tumors of neuroendocrine origin that are uncontrolled and have progressed
- Treatment of tumors in patients who have not responded to hormone therapy and chemotherapy
- Helping to reduce tumor growth and alleviate symptoms of carcinoid syndrome
- A suitable and reliable choice for physicians as a personalized therapy
- Reduction of tumor size, pain relief, and improvement in the patient’s quality of life
Dotatate (140 µg)
Sodium Ascorbate
Sodium Acetate
Mannitol
- Store the PARS‑LUTO TATE® kit in a freezer (-8°C to -20°C) and protected from light. The cold chain must be maintained under all circumstances.
- After radiolabeling, administer 177Lu‑DOTATATE immediately; otherwise, the radiolabeled solution remains stable for up to 7 days in a freezer (-8°C to -20°C).
- The PARS‑LUTO TATE® kit should not be used after the expiration date.
You must be logged in to post a comment.


